Your shopping cart is currently empty

DuP-697 is an irreversible, specific COX-2 inhibitor with IC50 values of 10 nM and 800 nM for human COX-2 and COX-1. DuP-697 also exhibits anti-angiogenic, anti-inflammatory, antipyretic and apoptotic effects.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $48 | In Stock | In Stock | |
| 5 mg | $106 | In Stock | In Stock | |
| 10 mg | $156 | In Stock | In Stock | |
| 25 mg | $262 | In Stock | In Stock | |
| 50 mg | $389 | In Stock | In Stock | |
| 100 mg | $572 | In Stock | In Stock | |
| 200 mg | $813 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $126 | In Stock | In Stock |
| Description | DuP-697 is an irreversible, specific COX-2 inhibitor with IC50 values of 10 nM and 800 nM for human COX-2 and COX-1. DuP-697 also exhibits anti-angiogenic, anti-inflammatory, antipyretic and apoptotic effects. |
| Targets&IC50 | COX-2 (human):10 nM, COX-1 (human):800 nM |
| In vitro | METHODS: DuP-697 (0, 12.5, 25, 50, 100, 200 μM, 36 hours) was used to treat K562 or CML cell lines. The effects on cell growth were evaluated by MTT assay, and the effects on cell apoptosis were detected by flow cytometry. RESULTS DuP-697 significantly inhibited the growth of K562 cells and primary CML cells with an IC50 value of 31.7 μM, and induced cell apoptosis in a concentration-dependent manner. [2] |
| In vivo | METHODS: DuP 697 (5 mg/kg, intraperitoneal injection) was used to treat rats 1 hour before thrombin injection to investigate its neurotoxic effects on dopaminergic neuronal degeneration in the substantia nigra (SN) of rats. RESULTS The loss of TH-ip neurons was partially attenuated in the SN of rats treated with DuP-697. [2] |
| Molecular Weight | 411.31 |
| Formula | C17H12BrFO2S2 |
| Cas No. | 88149-94-4 |
| Smiles | CS(=O)(=O)c1ccc(cc1)-c1cc(Br)sc1-c1ccc(F)cc1 |
| Relative Density. | 1.514g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 45 mg/mL (109.41 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.